secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K
Filed at:   2026-06-18T20:14:48+00:00
Accession:  0001104659-26-075730
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood shareholders approve 10M share increase to equity incentive plan
-------------------------------------------------------------------------

- Shareholders approved amendment increasing shares available under 2019 Equity Incentive Plan from 16M to 26M.
- All eight director nominees elected with over 97% of votes cast in favor.
- Non-binding advisory vote on executive compensation passed with ~95% of votes cast in favor.
- Ratification of KPMG as independent auditor for 2026 approved with ~97% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465926075730/0001104659-26-075730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465926075730/tm2618313d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-075730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer